These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 19166440)
1. Targets and tactics: the relative importance of HbA, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes. Woo V; Shestakova MV; Ørskov C; Ceriello A Int J Clin Pract; 2008 Dec; 62(12):1935-42. PubMed ID: 19166440 [TBL] [Abstract][Full Text] [Related]
2. Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA(1c) in subjects with Type 2 diabetes. Peter R; Dunseath G; Luzio SD; Chudleigh R; Choudhury SR; Owens DR Diabet Med; 2009 Oct; 26(10):974-80. PubMed ID: 19900228 [TBL] [Abstract][Full Text] [Related]
3. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus. Giugliano D; Ceriello A; Razzoli E; Esposito K Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710 [TBL] [Abstract][Full Text] [Related]
4. A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available. Ozmen S; Cil T; Atay AE; Tuzcu AK; Bahceci M Diabet Med; 2006 Oct; 23(10):1151-4. PubMed ID: 16978383 [TBL] [Abstract][Full Text] [Related]
5. The glucose triad and its role in comprehensive glycaemic control: current status, future management. Ceriello A Int J Clin Pract; 2010 Nov; 64(12):1705-11. PubMed ID: 20860758 [TBL] [Abstract][Full Text] [Related]
6. Targeting prandial hyperglycemia: how important is it and how best to do this? Monnier L; Colette C Curr Diab Rep; 2008 Oct; 8(5):368-74. PubMed ID: 18778585 [TBL] [Abstract][Full Text] [Related]
7. Glycaemic instability is an underestimated problem in Type II diabetes. Praet SF; Manders RJ; Meex RC; Lieverse AG; Stehouwer CD; Kuipers H; Keizer HA; van Loon LJ Clin Sci (Lond); 2006 Aug; 111(2):119-26. PubMed ID: 16613586 [TBL] [Abstract][Full Text] [Related]
8. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment. Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L; Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534 [TBL] [Abstract][Full Text] [Related]
9. The importance of glycated haemoglobin (HbA(1c)) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes. Yu PC; Bosnyak Z; Ceriello A Diabetes Res Clin Pract; 2010 Jul; 89(1):1-9. PubMed ID: 20494468 [TBL] [Abstract][Full Text] [Related]
10. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept. Monnier L; Colette C; Owens DR Diabetes Metab Res Rev; 2009 Jul; 25(5):393-402. PubMed ID: 19437415 [TBL] [Abstract][Full Text] [Related]
11. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes. Cavalot F Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513 [TBL] [Abstract][Full Text] [Related]
12. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives. Bonora E Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607 [TBL] [Abstract][Full Text] [Related]
13. Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetes. Schernthaner G; Guerci B; Gallwitz B; Rose L; Nicolay C; Kraus P; Kazda C Diabetes Metab; 2010 Nov; 36(5):389-94. PubMed ID: 20598608 [TBL] [Abstract][Full Text] [Related]
14. Does serum 1,5-anhydroglucitol establish a relationship between improvements in HbA1c and postprandial glucose excursions? Supportive evidence utilizing the differential effects between biphasic insulin aspart 30 and insulin glargine. Moses AC; Raskin P; Khutoryansky N Diabet Med; 2008 Feb; 25(2):200-5. PubMed ID: 18290862 [TBL] [Abstract][Full Text] [Related]
15. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study. Blonde L; Merilainen M; Karwe V; Raskin P; Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182 [TBL] [Abstract][Full Text] [Related]
16. Influence of preprandial vs. postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: a multicenter, randomized, parallel, open-label study (NCT00135096). Ratner R; Wynne A; Nakhle S; Brusco O; Vlajnic A; Rendell M Diabetes Obes Metab; 2011 Dec; 13(12):1142-8. PubMed ID: 21812890 [TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients. Davidson J; Koro C; Arondekar B; Lee BH; Fedder D Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267 [TBL] [Abstract][Full Text] [Related]
18. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels. Woerle HJ; Neumann C; Zschau S; Tenner S; Irsigler A; Schirra J; Gerich JE; Göke B Diabetes Res Clin Pract; 2007 Aug; 77(2):280-5. PubMed ID: 17240473 [TBL] [Abstract][Full Text] [Related]
19. Contribution of fasting and postprandial hyperglycemia to hemoglobin A1c in insulin-treated Japanese diabetic patients. Shimizu H; Uehara Y; Okada S; Mori M Endocr J; 2008 Aug; 55(4):753-6. PubMed ID: 18497454 [TBL] [Abstract][Full Text] [Related]
20. Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context. Abrahamson MJ Arch Intern Med; 2004 Mar; 164(5):486-91. PubMed ID: 15006824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]